The impacts of a cannabis extract on brain pathology and memory impairments associated with Alzheimer's disease in an APP-NL-G-F transgenic mouse model
dc.contributor.author | Robinson, Danika Andrea | |
dc.contributor.author | University of Lethbridge. Faculty of Arts and Science | |
dc.contributor.supervisor | McDonald, Robert J. | |
dc.date.accessioned | 2024-01-25T16:43:17Z | |
dc.date.available | 2024-01-25T16:43:17Z | |
dc.date.issued | 2023 | |
dc.degree.level | Masters | |
dc.description.abstract | Alzheimer’s Disease (AD) is a devastating neurodegenerative disorder that is categorized by progressive memory loss and cognitive deterioration. Amyloid-beta (Aꞵ) proteins accumulate within AD brains and trigger harmful chronic inflammation. By targeting both Aꞵ and inflammation, disease progression may be delayed. Cannabis is a plant containing THC and CBD. Previous work in our lab has shown that these compounds are ineffective at reducing AD pathology independently; however, research suggests they are more effective when combined. This project utilizes a THC/CBD combination extract to evaluate AD pathology in APP mice by assessing performance on memory-based behavioural tasks and by using protein markers to determine disease progression and severity. There were no treatment-related effects of the extract found via behavioural testing. However, the extract did decrease PFC 4G8-stained Aꞵ plaques. There were no other significant effects on Aꞵ, inflammation, or HPC cell volume found. Sex differences were found on various behavioural tasks. | |
dc.identifier.uri | https://hdl.handle.net/10133/6670 | |
dc.language.iso | en | |
dc.proquest.subject | 0317 | |
dc.proquest.subject | 0493 | |
dc.proquestyes | Yes | |
dc.publisher | Lethbridge, Alta. : University of Lethbridge, Dept. of Neuroscience | |
dc.publisher.department | Department of Neuroscience | |
dc.publisher.faculty | Arts and Science | |
dc.relation.ispartofseries | Thesis (University of Lethbridge. Faculty of Arts and Science) | |
dc.subject | Alzheimer's disease | |
dc.subject | cannabis extract | |
dc.subject | brain pathology | |
dc.subject | memory impairments | |
dc.subject | amyloid-beta proteins | |
dc.subject | chronic inflammation | |
dc.subject | THC | |
dc.subject | CBD | |
dc.subject.lcsh | Alzheimer's disease--Research | |
dc.subject.lcsh | Alzheimer's disease--Alternative treatment--Research | |
dc.subject.lcsh | Alzheimer's disease--Animal models | |
dc.subject.lcsh | Cannabis--Therapeutic use--Research | |
dc.subject.lcsh | Tetrahydrocannibinol--Therapeutic use--Research | |
dc.subject.lcsh | Amyloid beta-protein--Research | |
dc.subject.lcsh | Mice as laboratory animals | |
dc.subject.lcsh | Transgenic mice | |
dc.subject.lcsh | Cannabinoids--Therapeutic use--Research | |
dc.subject.lcsh | Plant extracts--Therapeutic use--Research | |
dc.subject.lcsh | Dissertations, Academic | |
dc.title | The impacts of a cannabis extract on brain pathology and memory impairments associated with Alzheimer's disease in an APP-NL-G-F transgenic mouse model | |
dc.type | Thesis |